Clinical and biochemical predictors of unfavorable prognosis for heart failure with preserved ejection fraction and type 2 diabetes mellitus

2015 ◽  
Vol 2 ◽  
pp. 33-48
Author(s):  
Iurii S. Rudyk ◽  
Ganna V. Bolotskykh ◽  
Maryna M. Udovychenko
2020 ◽  
Vol 73 (6) ◽  
pp. 463-470 ◽  
Author(s):  
Patricia Palau ◽  
Vicente Bertomeu-González ◽  
Juan Sanchis ◽  
Meritxell Soler ◽  
Rafael de la Espriella ◽  
...  

2021 ◽  
Vol 12 (2) ◽  
pp. 6-15
Author(s):  
A. A. Borisov ◽  
A. D. Gvozdeva ◽  
F. T. Ageev

Type 2 diabetes mellitus is known to increase the risk of the development of heart failure with preserved ejection fraction and worsen its symptoms. To date, no specific treatment has been shown to reduce morbidity and mortality in patients with heart failure with preserved ejection fraction. In this review, the authors summarized the existing evidence on how diabetes mellitus can promote the development and progression of heart failure with preserved ejection fraction. The authors also addressed medications including experimental ones that can potentially be beneficial in patients of this group.


2018 ◽  
Vol 20 (12) ◽  
pp. 1649-1652 ◽  
Author(s):  
Zoltán Papp ◽  
Tamás Radovits ◽  
Walter J. Paulus ◽  
Nazha Hamdani ◽  
Petar M. Seferović

Sign in / Sign up

Export Citation Format

Share Document